Page last updated: 2024-10-27

flumazenil and Alkaptonuria

flumazenil has been researched along with Alkaptonuria in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Alkaptonuria: An inborn error of amino acid metabolism resulting from a defect in the enzyme HOMOGENTISATE 1,2-DIOXYGENASE, an enzyme involved in the breakdown of PHENYLALANINE and TYROSINE. It is characterized by accumulation of HOMOGENTISIC ACID in the urine, OCHRONOSIS in various tissues, and ARTHRITIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Danda, S1
Mohan, S1
Devaraj, P1
Dutta, AK1
Nampoothiri, S1
Yesodharan, D1
Phadke, SR1
Jalan, AB1
Thangaraj, K1
Verma, IC1
Danda, D1
Jebaraj, I1

Other Studies

1 other study available for flumazenil and Alkaptonuria

ArticleYear
Founder effects of the homogentisate 1,2-dioxygenase (HGD) gene in a gypsy population and mutation spectrum in the gene among alkaptonuria patients from India.
    Clinical rheumatology, 2020, Volume: 39, Issue:9

    Topics: Alkaptonuria; Dioxygenases; Founder Effect; Homogentisate 1,2-Dioxygenase; Humans; India; Mutation;

2020